Gemcitabine and the blood brain barrier.

作者: J. R. DAVIS , C. FERNANDES , J. R. ZALCBERG

DOI: 10.1111/J.1445-5994.1999.TB00795.X

关键词:

摘要:

参考文章(5)
A J Wozniak, J J Crowley, S P Balcerzak, G R Weiss, C H Spiridonidis, L H Baker, K S Albain, K Kelly, S A Taylor, D R Gandara, R B Livingston, Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: A Southwest Oncology Group study Journal of Clinical Oncology. ,vol. 16, pp. 2459- 2465 ,(1998) , 10.1200/JCO.1998.16.7.2459
L Crinò, G Scagliotti, M Marangolo, F Figoli, M Clerici, F De Marinis, F Salvati, G Cruciani, L Dogliotti, F Pucci, A Paccagnella, V Adamo, G Altavilla, P Incoronato, M Trippetti, A M Mosconi, A Santucci, S Sorbolini, C Oliva, M Tonato, Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study. Journal of Clinical Oncology. ,vol. 15, pp. 297- 303 ,(1997) , 10.1200/JCO.1997.15.1.297
Paul E. Gormley, Diamon Gangji, James H. Wood, David G. Poplack, Pharmacokinetic Study of Cerebrospinal Fluid Penetration of cis-Diamminedichloroplatinum (II) Cancer Chemotherapy and Pharmacology. ,vol. 5, pp. 257- 260 ,(1981) , 10.1007/BF00434394
William Plunkett, Peng Huang, Varsha Gandhi, Preclinical characteristics of gemcitabine Anti-Cancer Drugs. ,vol. 6, pp. 7- 13 ,(1995) , 10.1097/00001813-199512006-00002